科伦药业(002422.SZ)：棕榈酸帕利哌酮注射液获得药品注册批准

Core Viewpoint - Kolun Pharmaceutical's subsidiary, Hunan Kolun Pharmaceutical Co., Ltd., has received drug registration approval from the National Medical Products Administration for its chemical drug "Paliperidone Palmitate Injection" [1] Group 1: Product Approval - The "Paliperidone Palmitate Injection" was developed by Janssen Pharmaceuticals and was first approved in the United States in 2009 [1] - The drug was imported into China in 2011 and utilizes long-acting microcrystal technology, allowing for administration once a month [1] Group 2: Indications - The injection is indicated for the treatment of acute and maintenance phases of schizophrenia [1]